Eli Lilly (LLY) PT Raised to $98 at Leerink Partners
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,183.46 +0.13%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Leerink Partners raised its price target on Eli Lilly (NYSE: LLY) to $98.00 (from $95.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Lilly's once-weekly basal insulin for type 2 diabetes
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- FDA clears Lilly's Olumiant for teens with severe alopecia areata
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
